Cidara Therapeutics Ownership | Who Owns Cidara Therapeutics?
Cidara Therapeutics Ownership Summary
Cidara Therapeutics is owned by 0.09% institutional investors, 4.73% insiders, and 95.18% retail investors. Prudential financial is the largest institutional shareholder, holding 0% of CDTX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.73% of its assets in Cidara Therapeutics shares.
CDTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cidara Therapeutics | 0.09% | 4.73% | 95.18% |
Sector | Healthcare Stocks | 46.98% | 7.90% | 45.12% |
Industry | Biotech Stocks | 44.85% | 7.67% | 47.48% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Prudential financial | - | - | - |
Renaissance | - | - | - |
Spire wealth management | - | - | - |
Mariner | - | - | - |
Point72 asset management | - | - | - |
Gsa capital partners llp | - | - | - |
Blackrock | - | - | - |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Geode capital management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Prudential financial | - | - | - |
Renaissance | - | - | - |
Spire wealth management | - | - | - |
Mariner | - | - | - |
Point72 asset management | - | - | - |
Gsa capital partners llp | - | - | - |
Blackrock | - | - | - |
Two sigma advisers, lp | - | - | - |
Tower research capital llc (trc) | - | - | - |
Geode capital management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Qube research | - | - | -52.00 |
Cubist systematic strategies | - | - | -290.00 |
Bnp paribas arbitrage, snc | - | - | -353.00 |
Jpmorgan chase | - | - | -451.00 |
Wells fargo & company/mn | - | - | -643.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Bvf inc/il | - | - | -6.86M |
Vanguard group | - | - | -3.35M |
Renaissance | - | - | -2.55M |
Alethea capital management | - | - | -1.60M |
Point72 asset management | - | - | -1.25M |
Sold Out
Holder | Change |
---|---|
Qube research | -52.00 |
Cubist systematic strategies | -290.00 |
Bnp paribas arbitrage, snc | -353.00 |
Jpmorgan chase | -451.00 |
Wells fargo & company/mn | -643.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2024 | 1 | -98.04% | 4,000 | -99.98% | - | 0.01% | - | -100.00% | - | -100.00% |
Mar 31, 2024 | 51 | 2.00% | 22,055,850 | -4.85% | 24 | 3.71% | 15 | -11.76% | 13 | 8.33% |
Dec 31, 2023 | 50 | -9.09% | 23,179,993 | -3.72% | 25 | 3.60% | 17 | -15.00% | 12 | -14.29% |
Sep 30, 2023 | 55 | 1.85% | 24,074,750 | -8.31% | 26 | 2.40% | 20 | -16.67% | 14 | 16.67% |
Jun 30, 2023 | 54 | - | 26,255,381 | -3.15% | 33 | 2.81% | 24 | -31.43% | 12 | 100.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 121.55K | 1.73% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 52.39K | 0.74% | - |
A4Investments SICAV SIF ACCI IlanaA2EURH | 45.50K | 0.65% | 2.50K |
Fidelity Extended Market Index | 28.19K | 0.40% | 3.79K |
Vifag 2002 SICAV | 24.39K | 0.35% | - |
Sun Life CC&L Group Income & Growth Seg | 17.53K | 0.25% | 17.53K |
BlackRock Extended Equity Market K | 10.91K | 0.16% | -5.00 |
iShares Micro-Cap ETF | 9.87K | 0.14% | - |
Fidelity Total Market Index | 9.33K | 0.13% | 3.19K |
Northern Small Cap Core I | 7.60K | 0.11% | 7.60K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 11, 2024 | Sandison Taylor | Chief Medical Officer | Sell | $10.75K |
Sep 11, 2024 | Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sell | $10.58K |
Jun 07, 2024 | Stein Jeffrey | President & CEO | Buy | $105.68K |
Mar 11, 2024 | Tari Leslie | CHIEF SCIENTIFIC OFFICER | Sell | $14.09K |
Mar 11, 2024 | Sandison Taylor | Chief Medical Officer | Sell | $13.84K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q3 | - | 2 |
2024 Q2 | 1 | - |
2024 Q1 | - | 4 |
2023 Q3 | 2 | 2 |
2023 Q2 | - | - |
CDTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools